New Key Statistics Module, Z-Score and F-Score
SZSE:002793 Key Ratios
Market Cap ¥ M | 4,198.09 |
Enterprise Value ¥ M | 5,343.01 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 1.80 |
Price/Sales | 1.81 |
Price/Free Cash Flow | 28.83 |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) ¥ M | 2,390.00 |
EPS (TTM) ¥ | -0.56 |
Beneish M-Score | -4.2 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -11.01 |
EV-to-EBITDA | -11.01 |
PEG | -- |
Shares Outstanding M | 1,087.59 |
Net Margin (%) | -25.42 |
Operating Margin % | -12.80 |
Pre-tax Margin (%) | -23.07 |
Quick Ratio | 0.75 |
Current Ratio | 0.94 |
ROA % (ttm) | -10.22 |
ROE % (ttm) | -21.86 |
ROIC % (ttm) | -8.02 |
Dividend Yield % | -- |
Altman Z-Score | 1.35 |
SZSE:002793 Number of Guru Trades
SZSE:002793 Volume of Guru Trades
Gurus Latest Trades with SZSE:002793
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:002793 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Luoxin Pharmaceuticals Group Stock Co Ltd Insider Transactions
No Available Data